The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
To find out more about the study, please visit our main site.
Latest blog posts
Celebrate your registers! Development: Encouraging researchers
Research Opportunities The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) is an observational cohort study, which has collected data on over 30,000 participants in the UK over more than two decades. This extensive dataset...
Celebrate your registers! Collaboration: Successful collaboration with patient groups
The BSRBR-RA regularly collaborates with patient support groups to guide the direction of their research. This involvement can take place through the ‘Registers and Research Committee’ at the British Society for Rheumatology, where lay members and patient groups are...
Celebrate your registers! Collaboration: Collaboration with other biologics registers
The BSRBR-RA is one of four biologics registers run by the British Society for Rheumatology: BSRBR-RA (University of Manchester) UK JIA Biologics Register (University of Manchester) Psoriatic Arthritis Register (University of Aberdeen) Ankylosing spondylitis...
Celebrate your registers! Collaboration: Collaboration with international research groups
The BSRBR-RA is fortunate to be able to collaborate with numerous different research groups both across the UK and internationally. As part of the JAK-pot collaboration, 19 registers internationally – including the British Society for Rheumatology Biologics Register...
Celebrate your registers! Influence: Influencing clinical guidelines
Data from the BSRBR-RA study has influenced clinical guidelines.
Celebrate your registers! Impact: Long-term outcome data
The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) study has been central in understanding the long-term safety and effectiveness of biologic, biosimilar and JAKi therapies for rheumatoid arthritis (RA). Over the past two...
Join us at the BSR Annual Conference, 28-30 April 2025!
#BSR25 We are thrilled that we will be at the BSR’s Annual Conference next month. This conference offers a wide variety of talks across all aspects of rheumatology and rheumatology research. We are pleased that we will be attending and have the opportunity to meet...
Meet a Register Champion
Introducing Anne-Marie, one of our fantastic register champions on the BSRBR-RA Study. We asked Anne-Marie some questions on how she recruits participants successfully, and how she stays on top of the follow ups. How do you identify eligible participants for BSRBR-RA?...
International Women’s Day – Women in Science
To continue our focus on inspirational women in science, to celebrate International Women's Day, we asked BSRBR-RA Chief Investigator, Professor Kimme Hyrich, about her route to research. What did you study at which University? I grew up in Canada and did most of my...
International Women’s Day – Women in Science
To celebrate International Women's Day, we spoke to one of our inspirational colleagues, Dr Lianne Kearsley-Fleet. Lianne has published many research papers on BSRBR-RA data, and is now Co-Lead Investigator with the UK JIA Biologics Register. We asked her some...
Contact Us
+44 (0) 161 306 6000
Recent Comments